An efficient preparation of labelling precursor of [ 11 C]L-deprenyl-D 2 and automated radiosynthesis
The synthesis of [ C]L-deprenyl-D for imaging of astrocytosis with positron emission tomography (PET) in neurodegenerative diseases has been previously reported. [ C]L-deprenyl-D radiosynthesis requires a precursor, L-nordeprenyl-D , which has been previously synthesized from L-amphetamine as starti...
Saved in:
Published in | EJNMMI radiopharmacy and chemistry Vol. 2; no. 1; p. 10 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
24.07.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The synthesis of [
C]L-deprenyl-D
for imaging of astrocytosis with positron emission tomography (PET) in neurodegenerative diseases has been previously reported. [
C]L-deprenyl-D
radiosynthesis requires a precursor, L-nordeprenyl-D
, which has been previously synthesized from L-amphetamine as starting material with low overall yields. Here, we present an efficient synthesis of L-nordeprenyl-D
organic precursor as free base and automated radiosynthesis of [
C]L-deprenyl-D
for PET imaging of astrocytosis. The L-nordeprenyl-D
precursor was synthesized from the easily commercial available and cheap reagent L-phenylalanine in five steps. Next,
-alkylation of L-nordeprenyl-D
free base with [
C]MeOTf was optimized using the automated commercial platform GE TRACERlab® FX C Pro.
A simple and efficient synthesis of L-nordeprenyl-D
precursor of [
C]L-deprenyl-D
as free base has been developed in five synthetic steps with an overall yield of 33%. The precursor as free base has been stable for 9 months stored at low temperature (-20 °C). The labelled product was obtained with 44 ± 13% (
= 12) (end of synthesis, decay corrected) radiochemical yield from [
C]MeI after 35 min synthesis time. The radiochemical purity was over 99% in all cases and specific activity was (170 ± 116) GBq/μmol.
A high-yield synthesis of [
C]L-deprenyl-D
has been achieved with high purity and specific activity. L-nordeprenyl-D
precursor as free amine was applicable for automated production in a commercial synthesis module for preclinical and clinical application. |
---|---|
ISSN: | 2365-421X |
DOI: | 10.1186/s41181-017-0029-5 |